Deshpande Milind 4
4 · Spero Therapeutics, Inc. · Filed Jan 6, 2021
Insider Transaction Report
Form 4
Deshpande Milind
Director
Transactions
- Award
Stock Option (right to buy)
2021-01-04$13.31/sh+2,629$34,992→ 2,629 totalExercise: $17.93Exp: 2031-01-04→ Common Stock (2,629 underlying)
Footnotes (2)
- [F1]This stock option shall vest in four quarterly installments on the last day of each calendar quarter during the calendar year subject to the Reporting Person's continued service as a non-employee director.
- [F2]This stock option was issued to the Reporting Person, who elected to take stock options in lieu of $35,000 in cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation policy.